新华医疗 (600587.SH)

今开: 最高: 成交量:

昨收: 最低: 成交额:

+ 收藏

利润表(单季度)(新华医疗)

导出到EXCEL
报表日期选择
  • 常用日期查询
  • 自定义年度查询
    日期范围
    报告期
    报告类型
    显示选项
关 闭
完整财报对比
2024年第三季度2024年第二季度2024年第一季度2023年第四季度2023年第三季度2023年第二季度2023年第一季度
上市前/上市后 上市后上市后上市后上市后上市后上市后上市后
报表类型 合并报表合并报表合并报表合并报表合并报表合并报表合并报表
一、营业总收入(元) 2,236,724,325.902,658,013,638.662,528,538,840.432,695,047,427.142,243,830,541.552,634,100,176.782,438,890,277.93
 营业收入(元) 2,236,724,325.902,658,013,638.662,528,538,840.432,695,047,427.142,243,830,541.552,634,100,176.782,438,890,277.93
二、营业总成本(元) 2,134,248,022.792,340,678,808.412,298,905,534.932,560,171,944.442,096,902,459.142,365,921,210.642,215,993,908.16
 营业成本(元) 1,665,796,955.791,899,720,858.391,904,427,546.661,980,056,974.091,608,511,620.461,883,210,255.701,799,527,585.72
 研发费用(元) 111,872,705.09101,963,486.0083,305,119.71152,050,244.98112,736,376.86105,020,783.1873,557,725.07
 营业税金及附加(元) 14,656,664.4621,868,220.0614,318,968.5425,437,312.8518,197,362.7218,692,242.0414,661,765.48
 销售费用(元) 232,675,460.47204,650,170.57204,257,617.10236,445,485.24236,843,033.28233,039,341.40206,355,574.53
 管理费用(元) 103,642,917.01109,317,065.9888,190,919.48169,053,820.04112,032,928.80125,627,367.39113,528,277.78
 财务费用(元) 5,603,319.973,159,007.414,405,363.44-2,871,892.768,581,137.02331,220.938,362,979.58
  其中:利息费用(元) 11,114,068.009,113,534.2413,623,404.337,221,231.0814,591,445.6211,131,962.9014,127,183.76
  其中:利息收入(元) 36,041,541.67-23,318,671.417,969,683.018,559,174.6733,226,781.29-16,358,977.254,419,263.22
 资产减值损失(元) 2,710,811.32-14,540,890.941,488,567.34-32,538,686.86-1,846,459.02-9,299,309.62-3,793,108.81
 信用减值损失(元) 7,687,155.51-5,710,197.38-17,728,723.88-74,609,343.12253,755.71-6,801,709.85-5,285,224.52
三、其他经营收益
 加:公允价值变动收益(元) ---525,036.80-27,673,770.2021,368,715.3418,316,041.72
 加:投资收益(元) 13,447,796.6020,592,064.2018,623,683.7825,388,671.6825,243,381.7619,456,378.2511,029,530.70
  其中:对联营企业和合营企业的投资收益(元) 13,427,047.7020,426,349.0613,146,011.2720,717,746.9023,574,453.8418,225,508.9111,813,901.92
 资产处置收益(元) 2,534.66144,500.4254,184.184,663,942.53-852,117.08--57,618.31
 其他收益(元) 34,600,732.529,350,496.076,273,998.649,285,826.442,388,041.426,736,928.862,175,577.71
四、营业利润(元) 160,925,333.72327,170,802.62238,345,015.5667,590,930.17144,440,915.00299,639,969.12245,281,568.26
 加:营业外收入(元) 763,234.491,477,891.291,959,729.573,857,238.623,150,251.512,506,122.191,071,163.52
 减:营业外支出(元) 5,081,757.641,179,776.79300,014.4624,366,626.281,651,031.84-7,302,416.3310,243,789.37
五、利润总额(元) 156,606,810.57327,468,917.12240,004,730.6747,081,542.51145,940,134.67309,448,507.64236,108,942.41
 减:所得税费用(元) 20,712,778.2444,433,724.8224,980,580.65-23,634,678.6617,741,961.2833,894,486.2534,075,975.14
六、净利润(元) 135,894,032.33283,035,192.30215,024,150.0270,716,221.17128,198,173.39275,554,021.39202,032,967.27
(一)按经营持续性分类
  持续经营净利润(元) 135,894,032.33283,035,192.30215,024,150.0270,716,221.17128,198,173.39275,554,021.39202,032,967.27
(二)按所有权归属分类
  归属于母公司股东的净利润(元) 132,739,308.31273,225,348.51211,036,820.1275,339,310.26119,967,445.64262,178,539.91196,511,980.14
  少数股东损益(元) 3,154,724.029,809,843.793,987,329.90-4,623,089.098,230,727.7513,375,481.485,520,987.13
 扣除非经常性损益后的净利润(元) 133,420,460.82264,683,231.09208,965,933.4964,348,667.02143,624,315.36227,805,487.81183,670,392.01
七、每股收益
 一、基本每股收益(元) 0.180.540.450.140.260.570.46
 二、稀释每股收益(元) 0.180.540.450.140.260.570.46
九、综合收益总额(元) 135,894,032.33283,098,086.43215,024,150.0270,738,120.17123,519,146.73280,233,048.05202,032,967.27
 归属于母公司所有者的综合收益总额(元) 132,739,308.31273,288,242.64211,036,820.1275,361,209.26115,288,418.98266,857,566.57196,511,980.14
 归属于少数股东的综合收益总额(元) 3,154,724.029,809,843.793,987,329.90-4,623,089.098,230,727.7513,375,481.485,520,987.13
公告日期 2024-10-302024-08-302024-04-302024-03-292023-10-252023-08-232023-04-28
审计意见(境内) 标准无保留意见

前瞻产业研究院